EUROPEAN BOARD ON VISCOSUPPLEMENTATION

EUROVISCO Good Medical Practice Recommendations for the Use of Viscosupplementation with Hyaluronic Acid in the Management of Knee Osteoarthritis

LABRHA is supporting Eurovisco by organizing its annual board since 2014.We are proud to be Eurovisco’s partner. Abstract Objective: Viscosupplementation (VS) by intra-articular injections of hyaluronic acid (HA) is a commonly used treatment of knee osteoarthritis. However, there are no clear recommendations for its use in clinical situations not usually Read more…

By admin, ago

EUROVISCO Recommendations for the Use of Viscosupplementation with Hyaluronic Acid in the Management of Hip Osteoarthritis

LABRHA is supporting Eurovisco by organizing its annual board since 2014.We are proud to be Eurovisco’s partner. Abstract The European Viscosupplementation Consensus Group (EUROVISCO) has published expert recommendations on the use of hyaluronic acid (HA) injections, also known as viscosupplementation, in the management of hip osteoarthritis. Based on a comprehensive Read more…

By admin, ago
EUROVISCO Guidelines for the Design and Conduct of Clinical Trials Assessing the Disease-Modifying Effect of Knee Viscosupplementation

EUROVISCO Guidelines for the Design and Conduct of Clinical Trials Assessing the Disease-Modifying Effect of Knee Viscosupplementation

LABRHA is supporting Eurovisco by organizing its annual board since 2014. We are proud to be Eurovisco’s partner. Abstract Objectives: Hyaluronic acid viscosupplementation is a commonly used intra-articular treatment for osteoarthritis (OA). Some recent preclinical and clinical trials have demonstrated a potential for its disease-modifying effects. The goal of this expert Read more…

By admin, ago